These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22552217)

  • 21. Histopathological effects of androgen deprivation in prostatic cancer.
    Civantos F; Soloway MS; Pinto JE
    Semin Urol Oncol; 1996 May; 14(2 Suppl 2):22-31. PubMed ID: 8725888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.
    Nishimura K; Arichi N; Tokugawa S; Yoshioka I; Kishikawa H; Ichikawa Y
    Int J Urol; 2007 Mar; 14(3):264-7. PubMed ID: 17430272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial.
    Solberg A; Haugen OA; Viset T; Bergh A; Tasdemir I; Ahlgren G; Widmark A; Angelsen A
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):55-61. PubMed ID: 20598453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognosis significance of prostatic markers in patients with prostatic adenocarcinoma undergoing total hormonal blockade].
    Regueiro López JC; Ruiz Alvarez Cienfuegos F; Leva Vallejo M; Requena Tapia MJ; Merchan García JA; Prieto Castro R; Alvarez Kindelan J
    Actas Urol Esp; 1995 May; 19(5):357-62. PubMed ID: 8659288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone ablation therapy: lightening the load for today's prostate cancer patient.
    Matthews PA
    Urol Nurs; 2007 Feb; 27 Suppl():3-11. PubMed ID: 17474637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leuprolide with flutamide for complete androgen ablation: therapeutic alternative for advanced prostatic cancer (stage D2).
    Chime-Udeh E
    Conn Med; 1991 Sep; 55(9):526-8. PubMed ID: 1748007
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur urol 2006;49:54-8.
    Sharma R; Sundar S
    Eur Urol; 2007 Apr; 51(4):1146. PubMed ID: 17161523
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur Urol 2006;49:54-58.
    Pitts WR
    Eur Urol; 2007 Mar; 51(3):864. PubMed ID: 16860461
    [No Abstract]   [Full Text] [Related]  

  • 30. Biochemical remission after resection of prostate cancer lung metastasis.
    Chao DH; Higgins JP; Brooks JD
    Urology; 2004 Mar; 63(3):584-5. PubMed ID: 15028469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leuprolide monotherapy for choroidal metastasis from prostate adenocarcinoma.
    Ameri H; Araujo JC; Gombos DS
    Arch Ophthalmol; 2012 Sep; 130(9):1225-6. PubMed ID: 22965610
    [No Abstract]   [Full Text] [Related]  

  • 32. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.
    Herr HW; O'Sullivan M
    J Urol; 2000 Jun; 163(6):1743-6. PubMed ID: 10799173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
    Cherrier MM; Rose AL; Higano C
    J Urol; 2003 Nov; 170(5):1808-11. PubMed ID: 14532781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial.
    Solberg A; Widmark A; Tasdemir I; Ahlgren G; Angelsen A
    Scand J Urol Nephrol; 2011 Sep; 45(4):233-8. PubMed ID: 21452932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addressing bone loss in the cancer survivor.
    O'Rourke ME; Ruble K
    Oncology (Williston Park); 2009 Feb; 23(2 Suppl Nurse Ed):23-7. PubMed ID: 19856585
    [No Abstract]   [Full Text] [Related]  

  • 36. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
    Homma Y; Akaza H; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y;
    Int J Urol; 2004 May; 11(5):295-303. PubMed ID: 15147545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is flutamide effective in patients with bilateral orchiectomy?
    Rothman KJ; Johnson ES; Sugano DS
    Lancet; 1999 Apr; 353(9159):1184. PubMed ID: 10210003
    [No Abstract]   [Full Text] [Related]  

  • 38. Coagulopathy, following medical therapy, for carcinoma of the prostate.
    Bern MM
    Hematology; 2005 Feb; 10(1):65-8. PubMed ID: 16019449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormones and radiation therapy in locally advanced adenocarcinoma of the prostate.
    Lawton CA
    Semin Radiat Oncol; 2003 Apr; 13(2):141-51. PubMed ID: 12728443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimally invasive treatment for localized adenocarcinoma of the prostate: review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy.
    Sharkey J; Chovnick SD; Behar RJ; Perez R; Otheguy J; Rabinowitz R; Steele J; Webster C; Donohue M; Solc Z; Huff W; Cantor A
    J Endourol; 2000 May; 14(4):343-50. PubMed ID: 10910150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.